News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sigma-Tau Pharmaceuticals Announces the U.S. Launch of VSL#3® JUNIOR



10/16/2012 9:40:06 AM

GAITHERSBURG, Md., Oct. 16, 2012 (GLOBE NEWSWIRE) -- Sigma-Tau Pharmaceuticals, Inc. announced today the U.S. launch of VSL#3® JUNIOR, a once-a-day, high-potency probiotic medical food for the dietary management of children who suffer from irritable bowel syndrome (IBS) and ulcerative colitis (UC). Unlike other marketed probiotics, VSL#3® JUNIOR is presently the only probiotic sold as a medical food for IBS and UC. Refrigerated VSL#3® JUNIOR contains 8 proprietary strains of 225 billion live bacteria, making it approximately 50 times more potent than the average probiotic.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES